FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 262.68 Million INR | 24.17% |
| 2022 | -16.85 Million INR | -66.11% |
| 2021 | 624.25 Million INR | -20.6% |
| 2020 | 909.42 Million INR | 32.36% |
| 2019 | 785.09 Million INR | -56.85% |
| 2018 | 1.61 Billion INR | 56.44% |
| 2017 | 1.01 Billion INR | 884.22% |
| 2016 | 147.45 Million INR | -56.88% |
| 2015 | 207.33 Million INR | 23.83% |
| 2014 | 167.43 Million INR | -36.65% |
| 2013 | 264.29 Million INR | 16.03% |
| 2012 | 244.3 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.69 Million INR | -95.64% |
| 2023 Q3 | 251.17 Million INR | 280.49% |
| 2023 Q4 | 53.73 Million INR | -78.61% |
| 2023 FY | - INR | 34.61% |
| 2023 Q1 | 109.36 Million INR | -43.95% |
| 2023 Q2 | -139.16 Million INR | -227.26% |
| 2022 FY | - INR | -66.11% |
| 2022 Q3 | -98.28 Million INR | -396.06% |
| 2022 Q1 | 49.35 Million INR | -72.22% |
| 2022 Q4 | 195.12 Million INR | 298.53% |
| 2022 Q2 | 33.19 Million INR | -32.74% |
| 2021 Q4 | 177.65 Million INR | 704.55% |
| 2021 Q1 | 257.77 Million INR | 153.31% |
| 2021 FY | - INR | -20.6% |
| 2021 Q2 | 157.02 Million INR | -39.09% |
| 2021 Q3 | 22.08 Million INR | -85.94% |
| 2020 Q4 | 101.76 Million INR | -50.13% |
| 2020 Q3 | 204.03 Million INR | -19.49% |
| 2020 Q2 | 253.41 Million INR | 15.24% |
| 2020 FY | - INR | 32.36% |
| 2020 Q1 | 219.9 Million INR | 137.34% |
| 2019 Q2 | 154.9 Million INR | -35.13% |
| 2019 Q4 | 92.65 Million INR | -27.84% |
| 2019 Q1 | 238.79 Million INR | -23.02% |
| 2019 Q3 | 128.4 Million INR | -17.11% |
| 2019 FY | - INR | -56.85% |
| 2018 Q2 | 467.1 Million INR | 80.75% |
| 2018 FY | - INR | 56.44% |
| 2018 Q4 | 310.21 Million INR | -30.7% |
| 2018 Q3 | 447.63 Million INR | -4.17% |
| 2018 Q1 | 258.42 Million INR | -36.23% |
| 2017 Q3 | 389.61 Million INR | 198.78% |
| 2017 Q4 | 405.22 Million INR | 4.01% |
| 2017 Q2 | 130.4 Million INR | 683.67% |
| 2017 FY | - INR | 884.22% |
| 2017 Q1 | 16.63 Million INR | -50.23% |
| 2016 FY | - INR | -56.88% |
| 2016 Q1 | 68.19 Million INR | 88.33% |
| 2016 Q2 | 13.04 Million INR | -80.88% |
| 2016 Q3 | -5.81 Million INR | -144.63% |
| 2016 Q4 | 33.43 Million INR | 674.44% |
| 2015 Q2 | 60.82 Million INR | 2.15% |
| 2015 Q4 | 36.21 Million INR | -24.61% |
| 2015 Q3 | 48.03 Million INR | -21.02% |
| 2015 FY | - INR | 23.83% |
| 2015 Q1 | 59.53 Million INR | -35.37% |
| 2014 Q3 | 21.75 Thousand INR | -99.94% |
| 2014 Q1 | 49.03 Million INR | -27.46% |
| 2014 FY | - INR | -36.65% |
| 2014 Q2 | 38.47 Million INR | -21.54% |
| 2014 Q4 | 92.11 Million INR | 423436.78% |
| 2013 Q2 | 37.45 Million INR | -36.23% |
| 2013 Q4 | 67.59 Million INR | -34.35% |
| 2013 Q3 | 102.97 Million INR | 174.96% |
| 2013 Q1 | 58.72 Million INR | 45.38% |
| 2013 FY | - INR | 16.03% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | 40.39 Million INR | -6.9% |
| 2012 Q3 | 43.39 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | -2494.646% |
| Biocon Limited | 41.52 Billion INR | 99.367% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 88.541% |
| Concord Biotech Limited | 4.65 Billion INR | 94.362% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 91.449% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | -178107.894% |
| Lyka Labs Limited | 167.58 Million INR | -56.742% |
| Panacea Biotec Limited | -200.6 Million INR | 230.948% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 10776.177% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | 24.821% |
| Supriya Lifescience Limited | 1.83 Billion INR | 85.691% |
| Syngene International Limited | 10.84 Billion INR | 97.578% |
| TAKE Solutions Limited | -1.05 Billion INR | 124.997% |
| Titan Biotech Limited | 360.29 Million INR | 27.093% |
| Transgene Biotek Limited | -4.33 Million INR | 6153.976% |
| Vanta Bioscience Limited | 14.19 Million INR | -1751.046% |